Luiz Felipe Fernandes Peixoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Luiz Felipe Fernandes Peixoto has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Daniele Lisboa Ribeiro
Department of Cell Biology, Histology and Embryology, Institute of Biomedical Sciences, Federal University of Uberlândia (UFU), Uberlândia 38405-318, MG, Brazil
2 shared publications - Foued Salmen Espindola
Universidade Federal de Uberlândia
2 shared publications - Renata Graciele Zanon
Universidade Federal de Uberlândia
2 shared publications - Allisson Benatti Justino
Universidade Federal de Uberlândia, Brazil
1 shared publication Celso de Oliveira Rezende Júnior
Institute of Chemistry Federal University of Uberlândia Uberlândia Minas Gerais Brazil
1 shared publicationDaniele Lisboa Ribeiro
Institute of Biomedical Sciences Federal University of Uberlândia Uberlândia Minas Gerais Brazil
1 shared publication
Latest Publications
- Open Access
- 28 August 2026
- Published by Wiley in ChemMedChem
- Vol. 21 (17) , e70471
Piperazine and Morpholine Protoporphyrin IX Derivatives Intensify Biomolecules Oxidation and Phototoxicity in Triple‐Negative Breast Cancer
Photodynamic therapy (PDT) is a clinically established approach that relies on the localized generation of reactive oxygen species (ROS) mediated by a photosensitizer (PS), light, and molecular oxygen. Protoporphyrin IX (PpIX) is an approved PS; however, its intracellular retention is limited, factor that can alter its overall photodynamic efficiency. In this study, we report how the design of PpIX derivatives bearing piperazine (PpIX‐Pip) or morpholine (PpIX‐Morp) substituents may modulate lipophilicity, cellular uptake, oxidative stress, and phototoxicity. The photodynamic activity of these derivatives was evaluated in the aggressive triple‐negative human breast cancer cell line MDA‐MB‐231. Both derivatives showed greater time‐dependent cellular retention and enhanced photodynamic activity compared to PpIX, promoting oxidative stress, and triggering loss of mitochondrial membrane potential and caspase‐3 activation. These results highlight the impact of rational structural modification of PpIX on photodynamic efficiency and provide valuable structure–activity relationship insights for the development of improved porphyrin‐based PS for PDT.
- 28 August 2026
- Published by Wiley in ChemMedChem
- Vol. 21 (17) , e70471
Open AccessPiperazine and Morpholine Protoporphyrin IX Derivatives Intensify Biomolecules Oxidation and Phototoxicity in Triple‐Negative Breast Cancer
Photodynamic therapy (PDT) is a clinically established approach that relies on the localized generation of reactive oxygen species (ROS) mediated by a photosensitizer (PS), light, and molecular oxygen. Protoporphyrin IX (PpIX) is an approved PS; however, its intracellular retention is limited, factor that can alter its overall photodynamic efficiency. In this study, we report how the design of PpIX derivatives bearing piperazine (PpIX‐Pip) or morpholine (PpIX‐Morp) substituents may modulate lipophilicity, cellular uptake, oxidative stress, and phototoxicity. The photodynamic activity of these derivatives was evaluated in the aggressive triple‐negative human breast cancer cell line MDA‐MB‐231. Both derivatives showed greater time‐dependent cellular retention and enhanced photodynamic activity compared to PpIX, promoting oxidative stress, and triggering loss of mitochondrial membrane potential and caspase‐3 activation. These results highlight the impact of rational structural modification of PpIX on photodynamic efficiency and provide valuable structure–activity relationship insights for the development of improved porphyrin‐based PS for PDT.
- Open Access
- 24 July 2026
- Published by Biosciences and Health in Biosciences and Health
- Vol. 4, 1-14
Estresse oxidativo e alterações morfológicas no hipocampo da prole de ratas hiperglicêmicas
O diabetes mellitus gestacional expõe o feto a um ambiente hiperglicêmico capaz de comprometer o desenvolvimento do sistema nervoso central, especialmente do hipocampo, estrutura altamente suscetível ao estresse oxidativo e às alterações morfológicas. O objetivo deste estudo foi avaliar as alterações morfológicas e os marcadores de estresse oxidativo no hipocampo da prole de ratas expostas à hiperglicemia durante a gestação. Ratas Wistar tiveram hiperglicemia induzida por estreptozotocina no quinto dia de gestação. Os hipocampos da prole foram coletados aos 7, 30 e 90 dias de vida para análises morfológicas e bioquímicas, incluindo a avaliação do equilíbrio redox. Os dados foram submetidos à análise estatística apropriada. As ratas hiperglicêmicas apresentaram hiperglicemia persistente durante a gestação, sem diferença expressiva na evolução da massa corporal em relação ao grupo controle. A prole exibiu menor índice de massa corporal, alterações morfológicas persistentes nos subcampos do hipocampo em todas as idades avaliadas, aumento da produção de espécies reativas de oxigênio, redução da capacidade antioxidante total e diminuição da atividade da superóxido dismutase. Além disso, observou-se redução da ativação da caspase-3 aos 30 e 90 dias de idade. Conclui-se que a hiperglicemia materna promove alterações morfológicas persistentes e comprometimento da capacidade antioxidante do hipocampo da prole, evidenciando que a exposição intrauterina ao ambiente hiperglicêmico interfere no desenvolvimento neural e mantém repercussões até a idade adulta em ratos.
- 24 July 2026
- Published by Biosciences and Health in Biosciences and Health
- Vol. 4, 1-14
Open AccessEstresse oxidativo e alterações morfológicas no hipocampo da prole de ratas hiperglicêmicas
O diabetes mellitus gestacional expõe o feto a um ambiente hiperglicêmico capaz de comprometer o desenvolvimento do sistema nervoso central, especialmente do hipocampo, estrutura altamente suscetível ao estresse oxidativo e às alterações morfológicas. O objetivo deste estudo foi avaliar as alterações morfológicas e os marcadores de estresse oxidativo no hipocampo da prole de ratas expostas à hiperglicemia durante a gestação. Ratas Wistar tiveram hiperglicemia induzida por estreptozotocina no quinto dia de gestação. Os hipocampos da prole foram coletados aos 7, 30 e 90 dias de vida para análises morfológicas e bioquímicas, incluindo a avaliação do equilíbrio redox. Os dados foram submetidos à análise estatística apropriada. As ratas hiperglicêmicas apresentaram hiperglicemia persistente durante a gestação, sem diferença expressiva na evolução da massa corporal em relação ao grupo controle. A prole exibiu menor índice de massa corporal, alterações morfológicas persistentes nos subcampos do hipocampo em todas as idades avaliadas, aumento da produção de espécies reativas de oxigênio, redução da capacidade antioxidante total e diminuição da atividade da superóxido dismutase. Além disso, observou-se redução da ativação da caspase-3 aos 30 e 90 dias de idade. Conclui-se que a hiperglicemia materna promove alterações morfológicas persistentes e comprometimento da capacidade antioxidante do hipocampo da prole, evidenciando que a exposição intrauterina ao ambiente hiperglicêmico interfere no desenvolvimento neural e mantém repercussões até a idade adulta em ratos.
- 25 March 2026
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 74 (3) , 359-372
Loss of Macrophage Migration Inhibitory Factor (MIF) Alters the Timing of Ventral Prostate Maturation in Mice
This study investigated the contribution of macrophage migration inhibitory factor (MIF) for the development of ventral prostate in pubertal and adult mice. Mice aged 30 or 60 days from C57BL/6 WT (wild-type) and MIF −/− (knockout) strains were studied. Histological analysis, immunohistochemistry (smooth muscle alpha-actin, vimentin, PCNA, WNT5a), serum testosterone, and western blotting for ERK1/2 were performed. Thirty-day-old MIF −/− mice exhibited higher testosterone serum levels, and the ventral prostate presented enlarged luminal area as well as decreased collagen and smooth muscle cell content. Regarding cell proliferation, there was an important reduction in MIF −/− mice of both ages. In addition, MIF −/− 30 mice presented elevated ERK activation and WNT5a scores in the prostate. This study showed that developmental change expected only at adulthood of prostate is already very evident at 30 days of age in MIF −/− mice, anticipating the pubertal development. Thus, MIF has a stimulative role in proliferation and also modulates androgenic stimuli in the prostate, which can contribute to gland development from puberty to adulthood.
- 25 March 2026
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 74 (3) , 359-372
Loss of Macrophage Migration Inhibitory Factor (MIF) Alters the Timing of Ventral Prostate Maturation in Mice
This study investigated the contribution of macrophage migration inhibitory factor (MIF) for the development of ventral prostate in pubertal and adult mice. Mice aged 30 or 60 days from C57BL/6 WT (wild-type) and MIF −/− (knockout) strains were studied. Histological analysis, immunohistochemistry (smooth muscle alpha-actin, vimentin, PCNA, WNT5a), serum testosterone, and western blotting for ERK1/2 were performed. Thirty-day-old MIF −/− mice exhibited higher testosterone serum levels, and the ventral prostate presented enlarged luminal area as well as decreased collagen and smooth muscle cell content. Regarding cell proliferation, there was an important reduction in MIF −/− mice of both ages. In addition, MIF −/− 30 mice presented elevated ERK activation and WNT5a scores in the prostate. This study showed that developmental change expected only at adulthood of prostate is already very evident at 30 days of age in MIF −/− mice, anticipating the pubertal development. Thus, MIF has a stimulative role in proliferation and also modulates androgenic stimuli in the prostate, which can contribute to gland development from puberty to adulthood.